Follow-up blood cultures in Staphylococcus aureus bacteremia: a probability-based optimization
- PMID: 36066759
- DOI: 10.1007/s10096-022-04487-4
Follow-up blood cultures in Staphylococcus aureus bacteremia: a probability-based optimization
Abstract
Staphylococcus aureus bacteremia (SAB) is a relevant finding which prompts a thorough diagnostic work-up. Follow-up blood cultures (BC) are essential in this work-up. We investigate the probability of detecting an ongoing bacteremia after initiation of active therapy according to the number of BC taken at key time points. A retrospective analysis of all patients with SAB in a 6-year period was performed. Total number of BCs taken and the positivity was registered for each day after start of therapy. A positivity-rate was corrected using a logistic mixed effects model. Observed detection frequencies were applied to calculate detection probabilities using binomial distributions. Three hundred and seventeen cases were withheld for analysis. A BC bottle positivity rate of 66.7% was found 1 day after initiation of active therapy, which decreased to 48.5% on day 4. When using 1 set of FU-BC, 73.4% of persisting SABs are detected. To maintain a probability of detection of ≥ 90%, 2 BC sets should be taken on day 2 and day 4 after start of therapy. In 10 of 109 patients with positive FU-BC, skip phenomena were registered, with a significant higher proportion in patients with < 4 BC bottles taken (14%) than when ≥ 4 BC bottles were taken (4.1%). We recommend taking 2 BC sets on days 2 and 4 after start of therapy in order to detect ≥ 90% of persisting SABs, limiting skip phenomena and blood volume required. We strongly advice against taking a single BC set as follow-up for SAB.
Keywords: Bacteremia; Blood cultures; Staphylococcus aureus.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Minejima E, Mai N, Bui N et al (2020) Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes. Clin Infect Dis 70:566–573 - DOI
-
- Ten Oever J, Jansen JL, Van Der Vaart TW, Schouten JA, Hulscher MEJL, Verbon A (2019) Development of quality indicators for the management of Staphylococcus aureus bacteraemia. J Antimicrob Chemother 74:3344–3351 - DOI
-
- Fowler VG, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066 (Available at: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/archinte.163.17... ) - DOI
-
- Fowler VG, Justice A, Moore C et al (2005) Risk factors for hematogenous complications of intravascular catheter–associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695–703 (Available at: https://academic.oup.com/cid/article-abstract/40/5/695/364816 ) - DOI
-
- Rosa R, Wawrzyniak A, Sfeir M, Smith L, Abbo LM (2016) Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia. J Hosp Med 11:27–32 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical